Mean weight loss of 19.2%I at 6 mg with no plateau and favorable safety profile in 48-week Phase 3 clinical trial – – Data ...

N. Gopalakrishna Iyer, MBBS, PhD, noting that the researchers were “quite surprised” by the overall survival achieved in the control arm, given the real-world setting of the trial.

M.G. Skinner Insurance Agency (MG Skinner), a specialty insurance broker and program administrator operating in all 50 states, has completed the accelerated implementation of Origami Risk's ...

Gilead Sciences' HIV therapies and liver drug Livdelzi drive Q3 revenue growth, offsetting weaker Veklury and Cell Therapy ...

Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability ...

Behavox, the AI company that transforms data into insights that safeguard and enhance businesses, today announced the launch of End-to-End Scenario Execution Alerts Reporting, a major enhancement to ...

Despite a decline in net sales and earnings, Molson Coors Beverage Co (TAP) focuses on brand strength and strategic growth ...

Q3 2025 Earnings Call Transcript November 3, 2025 TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $2.43, ...

Finally after almost a 4 month search and deliberation on what would replace my wife's car (1st gen Ford Figo TDCi) and our ...

According to a Securities and Exchange Commission (SEC) filing dated November 3, 2025 ( link ), boutique investment company ...

Molson Coors Beverage Company TAP has posted third-quarter 2025 results, wherein the top and bottom lines missed the Zacks ...